Chimeramycin A
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-00298 |
| CAS | 87084-47-7 |
| Molecular Weight | 911.17 |
| Molecular Formula | C48H82N2O14 |
| Purity | >98% |
Online Inquiry
Description
Chimeramycin A is produced by the strain of Streptomyces ambofaciens. It has anti-gram-positive bacterial and mycoplasma activities.
Specification
| Storage | -20°C |
| IUPAC Name | (4R,5S,6R,7S,9R,11E,13E,15S,16R)-6-(((2R,3R,4R,5S,6R)-5-(((2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-16-ethyl-7-formyl-5,9,13,15-tetramethyl-2-oxooxacyclohexadeca-11,13-dien-4-yl acetate |
| InChI | InChI=1S/C47H80N2O14/c1-15-35-26(3)20-25(2)16-18-36(61-39-19-17-34(48(11)12)29(6)56-39)27(4)21-33(24-50)43(28(5)37(59-32(9)51)22-38(52)60-35)63-46-42(53)41(49(13)14)44(30(7)58-46)62-40-23-47(10,55)45(54)31(8)57-40/h16,18,20,24,26-31,33-37,39-46,53-55H,15,17,19,21-23H2,1-14H3/b18-16+,25-20+/t26-,27+,28-,29+,30+,31-,33+,34-,35+,36?,37+,39-,40-,41+,42+,43+,44+,45-,46-,47+/m0/s1 |
| InChI Key | ASNJGNMYROPVAB-QRZIOQSRSA-N |
Properties
| Appearance | White Amorphous Powder |
| Antibiotic Activity Spectrum | gram-positive bacteria; mycoplasma |
| Melting Point | 108-110 °C |
| Solubility | Soluble in DMSO |
Recommended Products
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-02642 | Lactonamycin | Inquiry |
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-03753 | Baicalin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
